42-oxorapamycin
AssigneeAmerican Home Products Corporation
InventorGregory F. Von Burg
Life of this patent
Estimating the term…
Abstract
This invention provides an oxidized derivative of rapamycin in which the hydroxyl at the 42-position has been oxidized to the corresponding ketone or a pharmaceutically acceptable salt thereof, which by virtue of its immunosuppressive and antifungal activity is useful in treating transplantation rejection, host vs. graft disease, autoimmune diseases, diseases of inflammation, and fungal infections and a process for the preparation of this oxidized derivative of rapamycin. ##STR1##
Claims9
42-Oxorapamycin or a pharmaceutically acceptable salt thereof.
A method of treating transplantation rejection, host vs. graft disease, autoimmune diseases, and diseases of inflammation in a mammal by administering an effective amount of 42-oxorapamycin or a pharmaceutically acceptable salt thereof.
A method of treating fungal infections by administering an effective amount of 42-oxorapamycin or a pharmaceutically acceptable salt thereof.
A process for making 42-oxorapamycin from rapamycin using a ruthenium catalyst as an oxidant.
Dependencies are inferred from the claim text.